Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul;596(14):2865-2881.
doi: 10.1113/JP275558. Epub 2018 May 19.

Smoke-induced neuromuscular junction degeneration precedes the fibre type shift and atrophy in chronic obstructive pulmonary disease

Affiliations

Smoke-induced neuromuscular junction degeneration precedes the fibre type shift and atrophy in chronic obstructive pulmonary disease

Sophia Kapchinsky et al. J Physiol. 2018 Jul.

Abstract

Key points: Chronic obstructive pulmonary disease (COPD) is largely caused by smoking, and patient limb muscle exhibits a fast fibre shift and atrophy. We show that this fast fibre shift is associated with type grouping, suggesting recurring cycles of denervation-reinnervation underlie the type shift. Compared to patients with normal fat-free mass index (FFMI), patients with low FFMI exhibited an exacerbated fibre type shift, marked accumulation of very small persistently denervated muscle fibres, and a blunted denervation-responsive transcript profile, suggesting failed denervation precipitates muscle atrophy in patients with low FFMI. Sixteen weeks of passive tobacco smoke exposure in mice caused neuromuscular junction degeneration, consistent with a key role for smoke exposure in initiating denervation in COPD.

Abstract: A neurological basis for the fast fibre shift and atrophy seen in limb muscle of patients with chronic obstructive pulmonary disease (COPD) has not been considered previously. The objective of our study was: (1) to determine if denervation contributes to fast fibre shift and muscle atrophy in COPD; and (2) to assess using a preclinical smoking mouse model whether chronic tobacco smoke (TS) exposure could initiate denervation by causing neuromuscular junction (NMJ) degeneration. Vastus lateralis muscle biopsies were obtained from severe COPD patients [n = 10 with low fat-free mass index (FFMI), 65 years; n = 15 normal FFMI, 65 years) and healthy age- and activity-matched non-smoker control subjects (CON; n = 11, 67 years), to evaluate morphological and transcriptional markers of denervation. To evaluate the potential for chronic TS exposure to initiate these changes, we examined NMJ morphology in male adult mice following 16 weeks of passive TS exposure. We observed a high proportion of grouped fast fibres and a denervation transcript profile in COPD patients, suggesting that motor unit remodelling drives the fast fibre type shift in COPD patient limb muscle. A further exacerbation of fast fibre grouping in patients with low FFMI, coupled with blunted reinnervation signals, accumulation of very small non-specific esterase hyperactive fibres and neural cell adhesion molecule-positive type I and type II fibres, suggests denervation-induced exhaustion of reinnervation contributes to muscle atrophy in COPD. Evidence from a smoking mouse model showed significant NMJ degeneration, suggesting that recurring denervation in COPD is probably caused by decades of chronic TS exposure.

Keywords: cachexia; denervation; muscle atrophy; sarcopenia; smoking mouse.

PubMed Disclaimer

Conflict of interest statement

Jean Bourbeau receives grant funding from the (1) Research Chair COPD McGill University; (2) Research Institute of the McGill University Health Centre; (3) Research Chair COPD from GlaxoSmithKline; (4) CanCOLD consortium grant by Aerocrine, Almiral, AstraZeneca, Boehringer‐Ingleheim, GlaxoSmithKline, Novartis; and (v) Canadian Respiratory Research Network (CRRN) – Canadian Institutes of Health Research. R. Thomas Jagoe is a consultant for Immunotec Inc and related to this he has a patent for Compositions and Methods for Treatment of Muscle Wasting [US Patent Application 10/050,686 filed January 16 2003 (Harvard case 1829)]. None of the remaining authors declare any conflict of interest.

Figures

Figure 1
Figure 1. Muscle fibre type in COPD versus Control
A, representative immunoflorescence images labelled for type I (blue), type IIa (red), type IIx (green) and laminin (green), where grouped fast fibres are indicated (*). Fibres co‐expressing type IIa and IIx were seen in all groups and these appear reddish/green/brown in the images (bar = 100 μm). B, fibre type proportions. C, frequency of fibres completely surrounded by fibres of the same type (Grouped Fibres). *P < 0.05 versus Control; **P < 0.05 versus COPD patients with normal FFMI. [Color figure can be viewed at http://wileyonlinelibrary.com]
Figure 2
Figure 2. Muscle morphology in COPD versus Control
A, mean fibre cross‐sectional area by fibre type. B, fibre size distribution, with dashed vertical line representing fibres that were atrophied, defined as a size ≥2 standard deviations less than the mean for Controls. C, fraction of atrophied fibres in each group. *P < 0.05 versus Control; **P < 0.05 versus COPD patients with normal FFMI.
Figure 3
Figure 3. Evidence for denervation in COPD locomotor muscle
A, non‐specific esterase histochemically stained sections showing the presence of darkly staining small angular fibres in COPD and this was exacerbated in patients with low FFMI (bar = 100 μm). B, NCAM immunofluorescence (dark green in ii, iv, vi and viii) evident in COPD muscle in both type I (green labelled fibres in panels i, iii, v and vii denoted by ‘1’) and type II (unlabelled fibres in panels i, iii, v and vii denoted by ‘2’) fibres, and this was exacerbated in COPD patients with low FFMI (laminin is in red in panels i, iii, v and vii). Arrows denote very small fibres with positive NCAM signal. [Color figure can be viewed at http://wileyonlinelibrary.com]
Figure 4
Figure 4. Denervation and reinnervation responsive transcript responses in COPD locomotor muscle
A, transcripts that are up‐regulated with denervation to promote reinnervation (agrin, MuSK, Lrp4, rapsyn, FGFBP1); B, transcripts for AChR subunits. *P < 0.05 versus Control.
Figure 5
Figure 5. Neuromuscular junction morphology in mice following 16 weeks of tobacco smoke exposure
A, confocal images of the deep region of tibialis anterior muscle showing the post‐synaptic acetylcholine receptor cluster (α‐bungarotoxin, green) and pre‐synaptic motor neuron terminals (synaptophysin, red) at the neuromuscular junction in air‐exposed versus tobacco smoke‐exposed mice (bar = 10 μm). B, endplate morphology results, where the fraction of abandoned endplates = endplates with no detectable synaptophysin (bottom right). *P < 0.05 versus Air. [Color figure can be viewed at http://wileyonlinelibrary.com]

Similar articles

Cited by

References

    1. http://American Thoracic Society; http://American College of Chest Physicians. (2003). ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 167, 211–277. - PubMed
    1. Arbour D, Vande Velde C & Robitaille R (2017). New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction. J Physiol 595, 647–661. - PMC - PubMed
    1. Ausoni S, Gorza L, Schiaffino S, Gundersen K & Lomo T (1990). Expression of myosin heavy chain isoforms in stimulated fast and slow rat muscles. J Neurosci 10, 153–160. - PMC - PubMed
    1. Baehr LM, West DW, Marcotte G, Marshall AG, De Sousa LG, Baar K & Bodine SC (2016). Age‐related deficits in skeletal muscle recovery following disuse are associated with neuromuscular junction instability and ER stress, not impaired protein synthesis. Aging (Albany NY) 8, 127–146. - PMC - PubMed
    1. Baloh RH, Rakowicz W, Gardner R & Pestronk A (2007). Frequent atrophic groups with mixed‐type myofibers is distinctive to motor neuron syndromes. Muscle Nerve 36, 107–110. - PubMed

Publication types

Grants and funding

LinkOut - more resources